| Connected Entity | Relationship Type |
Strength
(mentions)
|
Documents | Actions |
|---|---|---|---|---|
|
organization
Prudential
|
Regulatory |
5
|
1 | |
|
organization
CIA
|
Regulatory |
5
|
1 |
This document page is a legal disclaimer and copyright notice from a 2018 Goldman Sachs document, specifically addressing regulatory compliance in the United Kingdom under the Financial Services and Markets Act 2000. It lists GSI's London address and its regulators (Prudential Regulation Authority and Financial Conduct Authority). The document bears a House Oversight Bates stamp, indicating it was produced as part of a congressional investigation.
This document is a legal disclaimer page (page 14) from a Goldman Sachs presentation or report, bearing the Bates stamp HOUSE_OVERSIGHT_026922, indicating it was part of a US Congressional investigation. It details regulatory compliance, licensing exemptions, and restrictions for distributing financial materials in various jurisdictions including Australia, Brazil, Chile, Dubai, Israel, Singapore, and the UAE. It specifically notes that Goldman Sachs entities are not licensed to provide investment advice in Israel and outlines 'wholesale client' restrictions in Australia.
This document is a standard legal disclaimer and privacy notice page from Goldman Sachs, dated 2018. It outlines regulatory compliance and investment warnings for Singapore, the United Arab Emirates, and the United Kingdom, alongside a data privacy statement regarding the EU. The document bears a Bates stamp indicating it is part of a House Oversight Committee investigation (HOUSE_OVERSIGHT_026908).
This document contains legal disclaimers and regulatory disclosures regarding financial services provided by Goldman Sachs entities across multiple jurisdictions, including Australia, Brazil, Chile, Dubai, and Israel. It specifies the regulatory bodies governing operations in each region, outlines restrictions on who may receive the materials (e.g., wholesale clients, sophisticated investors), and clarifying licensing exemptions.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity